Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Urgent hypertension as a biomarker for bevacizumab in the curative setting. Kassem, N., Shen, F., Jiang, G., Gardner, L., Philips, S., O'Neill, A. M., Miller, K. D., Suter, T., Cameron, D. A., Sledge, G. W., Schneider, B. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.15_suppl.548
View details for Web of Science ID 000442916000057